Bio-based 1,4 Butanediol
| Source | NASEM Database |
|---|---|
| Organization | BioAmber, Inc. |
| Market status | More information needed + No longer on the market |
| Industry | Industrial |
| Value chain stage | Input |
| Intended consumer | Commercial |
| Production process | Closed Production |
| Business models | B2B |
| Product categories | Chemical |
| Biotech components | Plant |
| Organization type(s) | Public Company |
| Funding types | Debtor-in-possession financing + Shareholder Investment |
| Known funding amount | 3,000,000 CAN |
| Country of production | USA |
| Country of distribution | Canada |
| Trading symbol | BIOA |
| Trading exchange | NYSE |
| Notes | BioAmber filed a voluntary petition for Chapter 11 bankruptcy in the U.S. on May 4, 2018 BioAmber Liquidates Assets August 2018 |
| Additional link #1 | biomassmagazine.com/articles/15519/bioamber-moves-… |